Top Markets
Coin of the day
LB Pharmaceuticals Inc Common Stock LB Pharmaceuticals Inc Common Stock

LB Pharmaceuticals Inc Common Stock

LBRX
Rangering i aksjer #8002
This biopharmaceutical firm is currently in the clinical development stage,... This biopharmaceutical firm is currently in the clinical development stage, concentrating on the creation of innovative treatments for neuropsychiatric disorders such as schizophrenia and bipolar depression. Central to their pipeline is LB-102, their primary investigational drug, which is a methylated variant of amisulpride.
Aksjekurs
$48.45
Markedsverdi
$1.39B
Endring (1 dag)
1.16%
Endring (1 år)
-
Land
US
Handel LB Pharmaceuticals Inc Common Stock (LBRX)

Kategori

Aksjeprishistorikk for LB Pharmaceuticals Inc Common Stock (LBRX)
Høyeste sluttskurs: $47.36 den 2026-08-01

Laveste sluttskurs: $15.87 den 2025-09-01
Aksjeprishistorikk for LB Pharmaceuticals Inc Common Stock fra 2025 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 24.35%
2025 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$542.09 38.27%
US
$1.03K 45.80%
NL
$121.53 -12.48%
AU
$138.18 464.67%
US
$759.27 6.90%
CH